Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

AXS Cannabis ETF

Cannabis stocks posted big gains Monday amid optimism about M&A and federal legalization in a rare burst of energy in the sector that's been trading mostly lower this year.

Cannabis Watch: Cannabis stocks rally on talk of M&A and latest moves toward possible reform of federal ban

Tilray Inc. shares are trading higher Monday after they traded down the past couple of sessions. There looks to be no company-evident news to explain the jump Monday, but the company is having an above-average volume day and was trending on StockTwits.

Tilray Sees A Bounce: Is This The Start Of The Reversal?

Cantor Fitzgerald releases notes on several major cannabis companies: Green Thumb Industries(OTCQX:GTBIF)

Analyst Lowers Price Targets On These Leading Stocks; $TLRY Enters Spirits Market – Cannabis Daily, November 4, 2021

Tilray, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced Thursday that two of its leading brands, SweetWater Brewing Company and RIFF Cannabis have collaborated for the exclusive U.S. launch of SweetWater RIFF – SweetWater's first ready-to-drink cocktail and its inaugural entry into the spirits category. SweetWater RIFF drinks are crafted with vodka and real fruit juices and come in two offerings, including SweetWater RIFF Citrus and SweetWater RIFF Strawberry Mule.

Tilray's Sweetwater Brand Partners With RIFF Cannabis, Launches Vodka Cocktail In A Can

Tilray Inc. (NASDAQ:TLRY) shares gained Wednesday after the stock was able to see a bounce off of support. The stock has made a double bottom off of the support level and looks to now be pushing back higher.

Is Tilray Stock Ready To Bounce, Make A Reversal?

Election Day in the U.S. spurs hope for the future opening of a massive new market.

Why Tilray Led Canadian Cannabis Stocks Higher Today

Cannabis marketplace Leafly Holdings, Inc. released its inaugural Cannabis Harvest Report on Wednesday revealing that cannabis is America's 5th most valuable crop. The report takes the first look at cannabis data, insights and projections across the 11 states where Americans can currently purchase both adult-use and medical cannabis.

Report: Cannabis Is America's 5th Most Valuable Crop, Earning More For Farmers Than Cotton Or Rice

JPMorgan Chase & Co has told prime brokerage clients it will no longer let them buy U.S. cannabis-related securities beginning Nov. 8, according to a letter seen by Reuters.

Exclusive-JPMorgan to restrict trading of U.S. cannabis stocks -letter

The cannabis industry is sizzling with opportunities; now is the time to grab these growth stocks.

3 Leading Cannabis Stocks to Buy in 2021 and Beyond

SNDL Inc.

Wall Street predicts mergers and acquisitions, while Italy takes a step toward legalization.

Why Canopy Growth, Aurora Cannabis, Tilray, and Sundial Stocks Are on Fire

Tilray, Inc. (NASDAQ:TLRY) reported its financial results this past Thursday for the first fiscal quarter of 2021, including a 43% increase in revenue that amounted to $168 million,  positioning the company on a $670 million annualized sales run rate.

What Will Drive Tilray's Stock Performance? Analyst's Thoughts On Canada's Largest Cannabis LPs

Cantor Fitzgerald on Monday downgraded Tilray TLRY, -1.90% to neutral from overweight and cut the cannabis stock's 12-month price target to $11.80 a share from $18. Analyst Pablo Zuanic said the firm "has difficulty making an investment case for them based on fundamentals vs.

Cantor Fitzgerald cuts Tilray rating to neutral from overweight

Village Farms International

Best Marijuana Stocks To Buy In Q4 2021 As top marijuana stocks… The post Top Canadian Cannabis Stocks To Buy In November? 4 To Add To Your List Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks To Buy In November? 4 To Add To Your List Right Now

Agrify

Turning Point Brands

Valley National

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

Cannabis Stocks in Focus This week

TLRY stock has plummeted since it was pumped to $67 in February. Tilray is one of the few meme stocks investors should be buying on the dip.

TLRY Stock: Why Meme Traders Should Buy the Dip In Tilray

Canaccord Genuity Corp released its cannabis market report indicating a 26% increase in revenue opportunities for US businesses, reaching up to $30 billion in revenue in 2022. The report also outlines a compelling value proposition for Multi-State-Operators (MSOs) even though cannabis equities continue to face headwinds despite positive fundamental performances.

Canaccord Genuity predicts 26% revenue increase for US cannabis market in 2022, says revenue likely to cross $30B

Is Tilray Stock A Buy, Sell, Or Hold After Recent Earnings?

Tilray, Inc. (TSX:TLRY) (NASDAQ:TLRY) confirmed Tuesday it has been chosen by the Luxembourg Ministry of Health as a supplier of medical cannabis products for the country's recently announced medical cannabis program. The Canadian cannabis giant will supply Luxembourg with a variety of its pharmaceutical-grade and Good Manufacturing Practice-certified medical marijuana products.

Tilray Continues Expanding Its Presence In Europe – Chosen To Supply Luxembourg's Medical Cannabis Program

NEW YORK--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a global pioneer in medical cannabis research, cultivation, production, and distribution, today announced it has been selected by the Luxembourg Ministry of Health as a supplier of Good Manufacturing Practice (GMP) certified medical cannabis products for the country's medical cannabis program. Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts an

Tilray Expands Medical Cannabis Footprint in Europe

Coinbase

Exxon Mobil

Coinbase Global, Inc (NASDAQ: COIN), Tilray, Inc (NASDAQ: TLRY) and Exxon Mobil Corporation (NYSE: XOM) have all settled into bullish flag patterns on the daily chart. The bull flag pattern is created with a sharp rise higher forming the pole, which is then followed by a consolidation pattern that brings the stock lower between a channel with parallel lines.

Coinbase, Tilray, Exxon Stocks Retrace Into This Bullish Pattern: What To Watch For

TLRY stock will lose more money for investors as Tilray's losses mount and the stock gets diluted in the longer term. The post Why It's Worth Betting Against Tilray Stock appeared first on InvestorPlace.

Why It's Worth Betting Against Tilray Stock

Evogene

Flora Growth Corp

Greenlane Holdings

HEXO Corp

High Tide

See Why a Slew of Pot Stocks Made the News This Week

Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.

Insider Cannabis: Time to buy US cannabis stocks - New York's legal gray area - Deals, deals, deals

News from Tilray this week included adding to its management team and signing a new distribution agreement.

Why Tilray Stock Jumped 10% This Week -- While Other Cannabis Names Didn't

TLRY stock is not one for the faint of heart. However, the signs are lining up for another solid rally in Tilray to close out 2021.

News for Tilray Brands Stock (TLRY)